Scilex Holding (NASDAQ:SCLXW – Get Free Report) shares traded down 2.2% during trading on Thursday . The company traded as low as $0.1999 and last traded at $0.2030. 4,089 shares traded hands during trading, a decline of 28% from the average session volume of 5,690 shares. The stock had previously closed at $0.2075.
Scilex Price Performance
The company has a fifty day simple moving average of $0.16 and a two-hundred day simple moving average of $0.14.
Scilex Company Profile
Scilex Holding Company is a specialty pharmaceutical firm focused on the commercialization, licensing and distribution of branded products for the management of acute and chronic pain. Established through a series of strategic acquisitions and internal development efforts, the company concentrates on non-opioid, topical and systemic therapies designed to address unmet needs in neuropathic and musculoskeletal pain. Scilex partners with healthcare providers, pharmacies and specialty distributors to bring its portfolio to patients across the United States.
The company’s flagship product, ZTlido® (lidocaine topical system 1.8%), is an FDA-approved prescription patch indicated for the relief of pain associated with postherpetic neuralgia.
Further Reading
- Five stocks we like better than Scilex
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
